Healthway Asia Limited

Healthway Asia Limited is a legitimate registered non-Hong Kong company duly registered under Part 16 of the Companies Ordinance (Cap. 622) of Hong Kong on 1972-03-10 (operating for 54 years). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation] (Statutory records last verified: December 2019).

Official Hong Kong government registers assign two statutory identifiers to Healthway Asia Limited: 1. Business Registration Number (BRN / UBI): [71473745] (statutory identifier for tax and commercial registration under Cap. 310); 2. Company Registration Number (CRN): [F0027099] (statutory filing number under Cap. 622). Commercial counterparties should verify both numbers on contracts and invoices.

Under Part 16 of the Companies Ordinance (Cap. 622), Healthway Asia Limited is a Registered Non-Hong Kong Company incorporated outside Hong Kong. In Hong Kong, its registered corporate governance records comprise: 1. Latest Annual Return (Form NN3, Section 788) for current directors and company secretary; 2. Form NN6 for interim alterations of directors or secretaries; 3. Form NN8 for Authorized Representatives registered in Hong Kong (Section 786) authorized to accept legal process and notices on its behalf; and 4. Initial Application Form NN1. Because the entity was incorporated outside Hong Kong, its overall equity share capital and complete register of members are maintained under the company laws of its home jurisdiction of incorporation (and listing disclosures if publicly listed), rather than local Form NAR1 or NSC1 filings.

Yes. Official filing registers of the Hong Kong Companies Registry confirm that Healthway Asia Limited has statutory filings on official record. Pursuant to Part 16 (Section 788) of the Companies Ordinance (Cap. 622), registered non-Hong Kong companies must deliver an Annual Return (Form NN3) to the Registrar of Companies within 42 days after each registration anniversary. Available verified original dossiers include: latest Annual Return of Non-Hong Kong Company (Form NN3 - detailing principal place of business in Hong Kong and authorised representatives), Application for Registration (Form NN1), Constitutive Documents, and Change of Secretary/Director/Authorised Representative notices (Form NN7 / NN8C), all carrying official ICRIS barcode verification.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Register Screening: Multi-agency verification across Hong Kong statutory regulators confirms Healthway Asia Limited does not hold special administrative or financial licences (such as SFC, HKMA, TCSP, or MSO), engaging in general commercial operations under the Companies Ordinance (Cap. 622); 2. Judicial Screening (Litigation & Winding-Up): screened against Hong Kong Judiciary cause books and winding-up registers under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32), with zero public compulsory winding-up petitions (HCCW) or civil litigation dockets currently indexed.

The principal place of business in Hong Kong of Healthway Asia Limited on official record is situated at: [ROOM C, 5/F, BLOCK 20, 555 VICTORIA ROAD, SOUTHERN DISTRICT, HONG KONG]. Pursuant to Part 16 (Section 791) of the Companies Ordinance (Cap. 622), all registered non-Hong Kong companies must maintain a principal place of business in Hong Kong and notify the Registrar within 15 days of any change (Form NN9) for the lawful service of statutory notices and court process.

When executing commercial contracts or conducting cross-border due diligence on Healthway Asia Limited (CRN: F0027099 / 8-digit BRN: 71473745), compliance verification covers four core pillars: 1. Statutory registration & dual identifiers: verify active registration under Cap. 622 Part 16 and Inland Revenue Department Business Registration (Cap. 310); 2. Hong Kong signing authority: inspect registered directors and Hong Kong Authorized Representatives appointed under Section 786 via latest Form NN3, Form NN6, and Form NN8 (non-Hong Kong companies execute documents through registered authorized representatives or directors under their home constitution, rather than local NAR1/ND2A forms); 3. Place of incorporation verification: inspect constituent documents and public disclosures from its home jurisdiction or stock exchange; and 4. Judicial litigation screening: search High Court civil actions (HCA) and winding-up petitions (HCCW).